Current Affairs

General Studies Prelims

General Studies (Mains)

Bharat Biotech

Bharat Biotech is a leading Indian biotechnology company. It focuses on developing vaccines and biotherapeutics. Founded in 1996, it has made significant contributions to public health. The company is known for its innovative research and development. It has produced vaccines for diseases like typhoid and COVID-19. Bharat Biotech plays a crucial role in India's healthcare landscape. Its work supports the nation's fight against infectious diseases.

Pandemic Preparedness Innovation Centre

The state government of Karnataka is planning to set up a Pandemic Preparedness Innovation Centre (PPIC) to tackle...

 February 13, 2023

iNCOVACC: A New Intranasal COVID-19 Vaccine for India

Bharat Biotech's intranasal COVID-19 vaccine, also known as iNCOVACC or BBV154, has been approved for use in India...

 December 25, 2022

Mixed Vaccine testing in India

India may soon begin testing the efficacy of two different Covid-19 vaccines which are mixed together to see...

 May 31, 2021

Public Sector Companies receive Govt support for vaccine production

The Government of India has decided to provide support to some public sector companies by advancing them grants...

 May 29, 2021

PM Modi Gets First Dose of Covid-19 Vaccine Covaxin

Prime Minister Narendra Modi took the first shot of the COVAXIN vaccine on March 1 at the All...

 March 1, 2021

IMA Endorses Safety of Two COVID Vaccines in India

India is set to start the COVID-19 vaccination drive from January 16. In order to create faith among...

 January 12, 2021

Guidelines to Airlines for Transporting Covid-19 Vaccines

The Directorate General of Civil Aviation (DGCA), the country's civil aviation regulator, has notified guidelines for airlines and...

 January 9, 2021

Bharat Biotech applied for ‘Emergency Use Authorisation’

The developer of indigenous COVID-19 vaccine, Bharat Biotech, has applied to the central drug regulator (DCGI) and asked...

 December 8, 2020

Bharat Biotech begins Phase III Trials of COVAXIN

Bharat Biotech has announced commencement of Phase III trials of India's indigenous COVAXIN vaccine on November 16, 2020.HighlightsThe...

 November 17, 2020

Bharat Biotech Receives Approval for Covaxin Trials

The Central Drugs Standard Control Organisation (CDSCO), a prominent health authority in India, has given the green light...

 June 29, 2020

Archives